---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-26-052956"
form_type: "8-K"
ticker: "PAHC"
cik: "0001069899"
company_name: "PHIBRO ANIMAL HEALTH CORP"
filed_at: "2026-04-30T23:59:59+00:00"
generated_at: "2026-05-15T00:32:00.305965+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Phibro Animal Health expands revolving credit facility by $125M to $435M

## Summary
- Revolver increased from $310M to $435M via Amendment No. 1 dated April 28, 2026.
- New lenders include Bank of America, Citibank, BMO, Compeer Financial, and others.
- Upfront fee of 0.15% of new commitments paid to incremental lenders.
- Proceeds available for general corporate purposes under the existing credit agreement.

## SEC filing metadata
- accession: 0001104659-26-052956
- form_type: 8-K
- ticker: PAHC
- cik: 0001069899
- company_name: PHIBRO ANIMAL HEALTH CORP
- filed_at: 2026-04-30T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 2.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1069899/000110465926052956/0001104659-26-052956-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1069899/000110465926052956/tm2613052d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-26-052956
- JSON: https://secwatch.observer/filing/0001104659-26-052956.json
- Plain text: https://secwatch.observer/filing/0001104659-26-052956.txt

## Source-grounded claims
- claim_id: 7f08ad99b7ee4490267c3897a9c7b077b847cd63
  claim: PHIBRO ANIMAL HEALTH CORP amended revolving credit of aggregate commitment of $435,000,000 with Coöperatieve Rabobank U.A., New York Branch.
  evidence_excerpt: 1, the revolving credit commitment available to the Company under the Original Credit Agreement has increased by $125,000,000, from $310,000,000 to an aggregate commitment of $435,000,000. The foregoing description of Amendment No. 1 does not purport to be complete and is qualified in its entirety by reference to Amendment No. 1, a copy of which has been filed as
  evidence_url: https://www.sec.gov/Archives/edgar/data/1069899/000110465926052956/0001104659-26-052956-index.htm
- claim_id: 107bf989eb5fde663d8bd903fddeffc932e1eb53
  claim: PHIBRO ANIMAL HEALTH CORP amended Amendment No. 1 with Coöperatieve Rabobank U.A., New York Branch valued at $125,000,000 (effective 2026-04-28).
  evidence_excerpt: On April 28, 2026, Phibro Animal Health Corporation (the “Company”) entered into Amendment No. 1 to its Credit Agreement (“Amendment No. 1”) with Coöperatieve Rabobank U.A., New York Branch, as administrative agent, collateral agent and L/C issuer, and each lender from time to time party thereto, which amends the Credit Agreement, dated as of July 3, 2024
  evidence_url: https://www.sec.gov/Archives/edgar/data/1069899/000110465926052956/0001104659-26-052956-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.